Frequency and Clinicopathological Characteristics of Presenilin 1 Gly206Ala Mutation in Puerto Rican Hispanics with Dementia
Manuscript Number:
12-1570R1
Author(s):
Steven E. Arnold, Jacob G. Dubroff, Jason Karlawish, Elisabeth McCarty-Wood, Mirna Negron, Jessica Nunez, John Q. Trojanowski, Vivianna Van Deerlin, Irving E. Vega, Li-San Wang, David Wolk, Sharon X. Xie
Disclosures
Steven E. Arnold
Consulting Fees:
Cowan Group - Board Membership,
Eli Lilly - Board Membership,
Bristol Myers Squibb - Board Membership,
Rush University Medical Center - Consultancy,
Philadelphia District Attorney's Office - Consultancy,
National Alzheimer Coordinating Center - Scientific Review Committee,
Bonner Kiernan Trebach & Cociata LLP - Consultancy
Lecture Fees:
Harvard University,
Trinitas Regional Medical Center,
University of Puerto Rico,
Massachusetts Alzheimer's Disease Research, Center/Memory Disorders Unit
Grants
Agency:
University of California San Diego - ADNI
Dates:
9/11/09-8/31/12
Agency:
Wyeth
Dates:
2/8/10-12/31/12
Agency:
Pfizer
Dates:
6/16/11-6/15/13
Agency:
Neuronetrix
Dates:
3/2/11-12/31/12
Agency:
National Institute of Health
Dates:
4/1/11-3/31/16
Agency:
Eli Lilly
Dates:
9/7/11-9/30/13
Agency:
American Health Assistance Foundation
Dates:
7/1/12-12/31/12
Agency:
University of California San Diego
Dates:
11/1/11-12/31/14
Agency:
Bristol Myers Squibb
Dates:
5/25/12/11/30/12
Jacob G. Dubroff
Lecture Fees:
Siemens: Applied Radiology Webinar (9/25/2012)
Grants
Agency:
Eli Lilly & Co.
Dates:
7/2011-9/2012
Agency:
Pfizer/Wyeth Pharmaceutical Co.
Dates:
7/2011-9/2012
Agency:
Elan/Janssen Pharmaceuticals
Dates:
7/2011-9/2012
Agency:
Siemens
Dates:
10/2011-11/2011
Jason Karlawish
Patents/Royalties
I a a co-holder on a license for an integrated neurodegenerative disease database held at University of Pennsylvania.
Elisabeth McCarty-Wood
Nothing to Disclose
Mirna Negron
Nothing to Disclose
Jessica Nunez
Nothing to Disclose
John Q. Trojanowski
Consulting Fees:
Dr. Trojanowski serves as an Associate Editor of Alzheimer's & Dementia.
Patents/Royalties
Dr. Trojanowski may accrue revenue in the future on patents submitted by the University of Pennsylvania wherein he is co-Inventor and he received revenue from the sale of Avid to Eli Lily as co-inventor on imaging related patents submitted by the University of Pennsylvania.
Grants
Agency:
NIH (AG 10124, AG 17586, AG-19724AG 024904, NS053488, AG029213)
Dates:
to date
Agency:
Bristol Myer Squib
Dates:
to date
Agency:
AstraZenica
Dates:
to date
Agency:
several non-profits
Dates:
to date
Vivianna Van Deerlin
Nothing to Disclose
Irving E. Vega
Nothing to Disclose
Li-San Wang
Nothing to Disclose
David Wolk
Nothing to Disclose
Sharon X. Xie
Consulting Fees:
Dr. Xie serves as a consultant to Roche on a clinical trial unrelated to this study.